Effect of diverse datasets on the predictive capability of ADME models in drug discovery

Drug Discovery Today

Volumn 6, Issue SUPPL.1, 2001, Pages

  Grass, George M ^a   Sinko, Patrick J ^b  

^a Lion Biosciences   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007483749     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1359-6446(01)00150-7     Document Type: Review

References (42)

1. PhRMA (2000) Why do drugs cost so much?
2. Beary J.F. et al. (1993) Basic research and the cost of health care. Science 262, 1358
3. Abelson, P.H. (1993) Improvements in health care. Science 260, 11
4. Prentis, R. A. and Walker, S. R. (1986) Trends in the development of new medicines by UK-owned pharmaceutical companies (1964- 1980). Br. J. Clin. Pharmacol. 21, 437- 443
5. Prentis, R.A. et al. (1988) Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964- 1985). Br J. Clin.Pharmacol. 25, 387- 396
6. Mattison, N. et al. (1984) The development of self-originated new drugs by Swiss pharmaceutical firms, 1960- 1980. Regul.Toxicol.Pharmacol. 4, 157- 173
7. Wardell, WM. and DiRaddo, J. (1980) The measurement of pharmaceutical innovation. J. Clin. Pharmacol. 20, 1- 9
8. Peakman, T. and Arlington, S. (2001) Putting the code to work: the promise of pharmacogenetics and pharmacogenomics. Drug Discov.World 2, 35- 40
9. Borchardt, R.T. et al. (1996) General principles in the characterization and use of model systems for biopharmaceutical studies. Pharm. Biotechnol. 8, 1- 11
10. Lesko, L.J. et al. (2000) Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans. J. Clin. Pharmacol. 40, 803- 814
11. Peck, C.C. et al. (1994) Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development. J. Clin. Pharmacol. 34, 111- 119
12. Sietsema, WK. (1989) The absolute oral bioavailability of selected drugs. Int. J. Clin. Pharmacol. Ther.Toxicol. 27, 179- 211
13. Lin, J.H. (1995) Species similarities and differences in pharmacokinetics. Drug Metab. Dispos. 23, 1008- 1019
14. Sinko, P.J., ed. (1999) Screening acceptable pharmacokinetic qualities in early drug discovery, Current Drugs
15. Spalding, D.J.M. et al. (2001) Combining high-throughput pharmacokinetic screens at the hits to leads stage of drug discovery. Drug Discov. Today 5 (Suppl.), S70- S76
16. Poulin, P. and Theil, F.P. (2000) A priori prediction of tissue: plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J. Pharm. Sci. 89, 16- 35
17. Camenisch, G. et al. (1998) Estimation of permeability by passive diffusion through Caco-2 cell monolayers using the drugs' lipophilicity and molecular weight. Eur. J. Pharm. Sci. 6, 317- 324
18. Norinder, U. et al. (1997) Theoretical calculation and prediction of Caco-2 cell permeability using MolSurf parametrization and PLS statistics. Pharm. Res. 14, 1786- 1791
19. Stewart, B.H. et al. (1995) Comparison of intestinal permeabilities determined in multiple in vitro and in situ models: relationship to absorption in humans. Pharm. Res. 12, 693- 699
20. Stewart, B.H. and Chan, O.H. (1998) Use of immobilized artificial membrane chromatography for drug transport applications. J. Pharm. Sci. 87, 1471- 1478
21. Dowty, M.E. and Dietsch, C.R. (1997) Improved prediction of in vivo peroral absorption from in vitro intestinal permeability using an internal standard to control for intra- and inter-rat variability. Pharm. Res. 14, 1792- 1797
22. Jezyk, N. et al. (1992) Permeability characteristics of various intestinal regions of rabbit, dog, and monkey. Pharm. Res. 9, 1580- 1586
23. Grass, G.M. and Sweetana, S.A. (1989) A correlation of permeabilities for passively transported compounds in monkey and rabbit jejunum. Pharm.Res. 6, 857- 862
24. Smith, P.L. (1996) Methods for evaluating intestinal permeability an metabolism in vitro. Pharm. Biotechnol. 8, 13- 34
25. Artursson, P. and Karlsson, J. (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem.Biophys. Res. Commun. 175, 880- 885
26. Winiwarter, S. et al. (1998) Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach. J. Med. Chem. 41, 4939- 4949
27. Gres, M.C. et al. (1998) Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm. Res. 15, 726- 733
28. Yu, L.X. and Amidon, G.L. (1999) A compartmental absorption and transit model for estimating oral drug absorption. Int. J. Pharm. 186, 119- 125
29. Sinko, P.J. et al. (1991) Predicting fraction dose absorbed in humans using a macroscopic mass balance approach. Pharm. Res. 8, 979- 988
30. Norris, D.A. et al. (2000) Development of predictive pharmacokinetic simulation models for drug discovery. J. Control. Release 65, 55- 62
31. Artursson, P. (1990) Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 79, 476- 482
32. Artursson, P. and Karlsson, J. (1991) Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175, 880- 885
33. Amidon, G.L. et al. (1988) Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res. 5, 651- 654
34. Palm, K. et al. (1996) Correlation of drug absorption with molecular surface properties. J. Pharm. Sci. 85, 32- 39
35. Palm, K. et al. (1998) Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors. J. Med. Chem. 41, 5382- 5392
36. Egan, W.J. et al. (2000) Prediction of drug absorption using multivariate statistics. J. Med. Chem. 43, 3867- 3877
37. Artursson, P. (1990) Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sci. 79, 476- 482
38. Ren, S. and Lien, E.J. (2000) Caco-2 cell permeability vs human gastrointestinal absorption: QSPR analysis. Prog. Drug. Res. 54, 1- 23
39. Grass, G.M. (1997) Simulation models to predict oral drug absorption from in vitro data. Adv. Drug Deliv. Rev. 23, 199- 219
40. Makhey, V.D. et al. (1998) Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells. Pharm. Res. 15, 1160- 1167
41. Amidon, G. et al. (1988) Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm. Res. 5, 651- 654
42. Palm, K. et al. (1997) Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharm. Res. 14, 568- 571